4//SEC Filing
ESBER HENRY JEMIL 4
Accession 0001437749-19-006428
CIK 0001411879other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 7:27 PM ET
Size
5.6 KB
Accession
0001437749-19-006428
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2019-04-01$5.48/sh+1,643$9,004→ 28,734 totalFrom: 2019-04-01Exp: 2029-04-01→ Common Stock (1,643 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on April 1, 2019 of 1,643 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2019 and was valued on March 29, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeother
Related Parties
1- filerCIK 0001391501
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 7:27 PM ET
- Size
- 5.6 KB